Through PGC-1α upregulation, RTK/Shc signaling was shown to drive the glucose dependence of HER2+ breast cancer cells, which leads to resistance to therapeutic effectiveness of phenformin (another biguanide targeting mitochondrial respiration) [59]. This evidence concerns the gene PPARGC1A and breast carcinoma.